Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

EGFR mutations in malignant pleural effusion of non-small cell lung cancer: a case report.

Lung cancer (Amsterdam, Netherlands) - 1 Sept 2005

Huang Ming-Jer, Lim Ken-Hong, Tzen Chin-Yuan, Hsu Han-Shui, Yen Yun, Huang Biing-Shiun

Abstract excerpt

EGFR mutations have been shown to correlate with the clinical responsiveness to epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI). The detection of EGFR mutations in non-small cell lung cancer (NSCLC) is important from the perspective of targeted anticancer therapy. We report the first case showing that the status of EGFR mutations can be successfully determined in malignant pleural effusion...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Gefitinib

Share to Gene Deletion

Share to Pleural Effusion, Malignant

Share to Positron-Emission Tomography

Share to Quinazolines

Source

Identifiers

PMID: 15913841
DOI: 10.1016/j.lungcan.2005.02.016

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

EGFR mutations in malignant pleural effusion of non-small cell lung cancer: a case report.PMID 15913841Read ↗

Role of molecular testing for malignant pleural effusion in targeted therapy for advanced non-small cell lung cancer.Semantic proximity Read ↗

Cytology smears as diagnostic material for EGFR gene testing in non-small cell lung cancer.Semantic proximity Read ↗

Cytology‐based gene mutation tests to predict response to anti‐epidermal growth factor receptor therapy: A reviewSemantic proximity Read ↗

Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma.Semantic proximity Read ↗

Epidermal growth factor receptor mutations in cells from non-small cell lung cancer malignant pleural effusions.Semantic proximity Read ↗

Epidermal Growth Factor Receptor Mutation and Anaplastic Lymphoma Kinase Gene Fusion: Detection in Malignant Pleural Effusion by RNA or PNA Analysis.Semantic proximity Read ↗

Detection of epithelial growth factor receptor mutations in cerebrospinal fluid from patients with lung adenocarcinoma suspected of neoplastic meningitis.Semantic proximity Read ↗

Detection and comparison of epidermal growth factor receptor mutations in cells and fluid of malignant pleural effusion in non-small cell lung cancer.Semantic proximity Read ↗

Clinical impact of pleural fluid carcinoembryonic antigen on therapeutic strategy and efficacy in lung adenocarcinoma patients with malignant pleural effusion.Semantic proximity Read ↗

Application of PCR methods to evaluate EGFR, KRAS and BRAF mutations in a small number of tumor cells in cytological material from lung cancer patients.Semantic proximity Read ↗

Frequency of EGFR mutations in lung adenocarcinoma with malignant pleural effusion: Implication of cancer biological behaviour regulated by EGFR mutation.Semantic proximity Read ↗

EGFR Mutation Status in Lung Adenocarcinoma-Associated Malignant Pleural Effusion and Efficacy of EGFR Tyrosine Kinase Inhibitors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.